SASKATOON, Saskatchewan--(BUSINESS WIRE)--#agriculture--A fresh new name and logo was recently revealed for Saskatoon’s food and ingredient processing cluster: Prairie Food Link. Joanne Baczuk, Director of Ecosystem Development with Ag-West Bio, has be
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the upcoming presentation of mature Phase 2 data evaluating zanidatamab in co
Canadian workers are slowly reprioritizing taking time off, but those using all of their vacation days remain below pre-pandemic levels. TORONTO--(BUSINESS WIRE)--An average of three in 10 (29%) working Canadians surveyed say they used all of their vac
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$IMV #DeliveryPlatform--IMV Inc. (the “Corporation” or “IMV”) (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies base
New CEO Graham Beesley to start January 1 CINCINNATI--(BUSINESS WIRE)--BiOWiSH Technologies, Inc. today announced the upcoming retirement of Chief Executive Officer, Ian Edwards, effective December 31, 2022, and the appointment of Graham Beesley as CEO o
OTTAWA, Ontario--(BUSINESS WIRE)--#HR--BioTalent Canada’s BioSkills Recognition Program has been updated with National Occupational Standards that allow new talent to distinguish themselves to prospective biotech employers. The BioSkills Recognition Pr
Raven Debuts Driverless Tillage and Driver Assist Harvest Solutions at CNH Industrial Tech Day Event SIOUX FALLS, S.D.--(BUSINESS WIRE)--#DriverlessAgTechnology--Raven Industries debuted two new autonomous agriculture solutions at CNH Industrial’s Tech
Leader in health and wellness products bringing concurrent planning to its global operations OTTAWA, Ontario--(BUSINESS WIRE)--Kinaxis® Inc. (TSX: KXS), the authority in driving agility for fast, confident decision-making in an unpredictable world, anno
Ingredient innovator deepens investment to scale up commercialization with its largest tranche of funding to date INDIANAPOLIS--(BUSINESS WIRE)--Equinom, the company on a mission to cultivate better food from the ground up, has announced a $35 mill
Results show overall confirmed objective response rate (cORR) of 33%, disease control rate (DCR) of 92%, and median progression-free survival (mPFS) of 9.6 months Data support further investigation of zanidatamab in combination with palbociclib and fu
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.